Evigrade

Droperidol

First-generation antipsychotic, butyrophenone. Used as antiemetic.

ATC code: N05AD08

Brand names: Inapsine

Updated · Methodology

Indications

How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

Blocks D2 receptors in the chemotrigger zone of the medulla – suppresses nausea. Also blocks alpha-1 adrenoceptors (hypotension) and hERG potassium channels (QT prolongation). added a boxed warning in 2001 for torsades de pointes even at low PONV doses.

Safety

Contraindications

  • QTc above 440 ms (men) or 450 ms (women)
  • Combination with other QT-prolongers (amiodarone, sotalol, high-dose ondansetron)
  • Hypokalaemia or hypomagnesaemia
  • Bradycardia below 55

Serious adverse effects

  • Torsades de pointes
  • Sudden cardiac death
  • Neuroleptic malignant syndrome

Common adverse effects

  • Hypotension
  • Sedation
  • Extrapyramidal symptoms
  • QT prolongation

Pregnancy: can you take Droperidol?

Limited data. Not used in caesarean section (hypotension risk).

Breastfeeding: can you take Droperidol?

Interrupt breastfeeding for 24 hours after single dose.

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Drug–drug interactions

4 pairs found. Sorted from critical to minor.

CriticalAmiodaroneClass III antiarrhythmics (Vaughan Williams)

Mechanism

Dual QT prolongation (amiodarone 30-50 ms, droperidol 10-20 ms). boxed warning on droperidol.

Symptoms

QTc above 500 ms, syncope, torsades de pointes risk.

Management

Combination contraindicated. Alternative – low-dose ondansetron or metoclopramide.

Pair details →Amiodarone →

CriticalMethadoneSynthetic opioid, full mu-receptor agonist

Mechanism

Dual QT prolongation, especially with methadone above 80 mg/day.

Symptoms

QTc above 500 ms, syncope, torsades de pointes risk.

Management

Combination contraindicated.

Pair details →Methadone →

CriticalSotalolNon-selective beta blocker with class III antiarrhythmic activity

Mechanism

Dual QT prolongation.

Symptoms

QTc above 500 ms, syncope, torsades de pointes risk.

Management

Combination contraindicated.

Pair details →Sotalol →

MajorOndansetron5-HT3 serotonin receptor antagonist

Mechanism

Additive QT prolongation (ondansetron 10-15 ms + droperidol 10-20 ms).

Symptoms

QTc above 500 ms, syncope, torsades de pointes risk.

Management

Choose one antiemetic or use ECG monitoring.

Pair details →Ondansetron →

Label mentions18 mentions

Verbatim lines from the interaction sections, in the language of the label

From this drug’s label

  • Majorantiarrhythmicsclass named in the label
    «Potentially Arrhythmogenic Agents:: Any drug known to have the potential to prolong the QT interval should not be used together with droperidol. Possible pharmacodynamic interactions can occur…»

    FDA, section 7 · Open on DailyMed

  • Majorantihistaminesclass named in the label
    «Potentially Arrhythmogenic Agents:: Any drug known to have the potential to prolong the QT interval should not be used together with droperidol. Possible pharmacodynamic interactions can occur…»

    FDA, section 7 · Open on DailyMed

  • Moderatecalcium channel blockersclass named in the label
    «Potentially Arrhythmogenic Agents:: Any drug known to have the potential to prolong the QT interval should not be used together with droperidol. Possible pharmacodynamic interactions can occur…»

    FDA, section 7 · Open on DailyMed

  • Moderatediureticsclass named in the label
    «Potentially Arrhythmogenic Agents:: Caution should be used when patients are taking concomitant drugs known to induce hypokalemia or hypomagnesemia as they may precipitate QT prolongation and…»

    FDA, section 7 · Open on DailyMed

  • barbituratesclass named in the label
    «CNS Depressant Drugs:: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with droperidol. When patients have…»

    FDA, section 7 · Open on DailyMed

  • opioidsclass named in the label
    «CNS Depressant Drugs:: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with droperidol. When patients have…»

    FDA, section 7 · Open on DailyMed

From other drugs’ labels

  • CriticalPimozide
    «DRUG INTERACTIONS: Because pimozide prolongs the QT interval of the electrocardiogram, an additive effect on QT interval would be anticipated if administered with other drugs, such as phenothiazines…»

    FDA, section 7 · Open on DailyMed

  • CriticalZiprasidone
    «CONTRAINDICATIONS: dofetilide, sotalol, quinidine, other Class Ia and III anti-arrhythmics, mesoridazine, thioridazine, chlorpromazine, droperidol, pimozide, sparfloxacin, gatifloxacin, moxifloxacin…»

    FDA, section 4 · Open on DailyMed

  • «Drugs Prolonging the QT Interval: BARHEMSYS causes dose- and concentration-dependent QT prolongation [see Clinical Pharmacology (12.2) ] . To avoid potential additive effects, avoid use of BARHEMSYS…»

    FDA, section 7 · Open on DailyMed

  • «Sustancias que pueden desencadenar torsades de pointes: - ciertos antipsicóticos: fenotiazinas (por ejemplo, clorpromazina, ciamemazina, levomepromazina, tioridazina, trifluoperazina), benzamidas…»

    AEMPS, section 4.5 · Open on CIMA

  • ModerateClozapine
    «Potential for Other Drugs to Affect Clozapine: Use caution when administering concomitant medications that prolong the QT interval or inhibit the metabolism of clozapine. Drugs that cause QT…»

    FDA, section 7 · Open on DailyMed

  • ModerateFluoxetine
    «Drugs that Prolong the QT Interval: Do not use fluoxetine in combination with thioridazine or pimozide. Use fluoxetine with caution in combination with other drugs that cause QT prolongation. These…»

    FDA, section 7 · Open on DailyMed

  • «Medicamentos afectados por alteraciones de los niveles de potasio: Algunos antipsicóticos (p.ej., trioridazina, clorpromazina, levomepromazina, trifluoperazina, ciamemazina, sulpirida, sultoprida…»

    AEMPS, section 4.5 · Open on CIMA

  • ModerateIndapamide
    «Medicamentos que ocasionan “torsades de pointes”, pero sin limitarse a: butirofenonas (ej. droperidol, haloperidol),»

    AEMPS, section 4.5 · Open on CIMA

  • ModerateRivastigmine
    «Dado que la bradicardia constituye un factor de riesgo en la aparición de torsades de pointes, se debe observar con precaución e incluso puede requerirse una monitorización clínica (ECG), si se…»

    AEMPS, section 4.5 · Open on CIMA

  • «Clinically-Significant Drug Interactions: Droperidol Use with caution QT interval prolongation»

    FDA, section 7 · Open on DailyMed

  • «Antipsicóticos ( amisulprida , haloperidol, droperidol, mesoridazina, pimozida, sertindol, tioridazina y clozaril )»

    AEMPS, section 4.5 · Open on CIMA

  • «Clinically Significant Drug Interactions: E xamples: Specific antipsychotics (e.g., ziprasidone, iloperidone, chlorpromazine, mesoridazine, droperidol); specific antibiotics (e.g., erythromycin…»

    FDA, section 7 · Open on DailyMed

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Droperidol used for?

Droperidol is evaluated for the following indications with varying evidence strength: Postoperative nausea and vomiting (evidence tier B). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Droperidol?

Common side effects of Droperidol (≥ 1 in 100): Hypotension, Sedation, Extrapyramidal symptoms, QT prolongation. See the Safety section for uncommon and serious reactions.

Is Droperidol safe during pregnancy?

Limited data. Not used in caesarean section (hypotension risk).

Is Droperidol compatible with breastfeeding?

Interrupt breastfeeding for 24 hours after single dose.

Who should not take Droperidol?

Droperidol is contraindicated in: QTc above 440 ms (men) or 450 ms (women); Combination with other QT-prolongers (amiodarone, sotalol, high-dose ondansetron); Hypokalaemia or hypomagnesaemia; Bradycardia below 55. Full list in the Safety section.

Official sources

Direct links to regulator labels. Open in a new tab.

Other drugs in this group

Fabomotizole, Haloperidol, Hydroxyzine, Melissa officinalis (leaf extract), Lorazepam, Phenazepam, Valeriana officinalis (root extract), Aripiprazole